AdvertisementFDA Panel Endorses Gene Therapy For A Form Of Childhood BlindnessOctober 12, 2017Rob SteinfacebookEmailA panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. (Spark Therapeutics)